EFL

Cohort Year: 2021-2022

Tracks: Life Sciences

VISIT WEBSITE

Isla Technologies

Isla Technologies is developing an intravascular cellular implant to deliver insulin to patients suffering from type 1 diabetes, providing precise blood glucose control and eliminating the need for insulin injections.